


Chemicals | Small Cap
Rossari Biotech Ltd. presents a strong financial profile, characterized by exceptional growth, outstanding profitability, and a very secure, low-debt structure. The company is expanding rapidly, with significant increases in revenue, profits, and assets, indicating high market demand and substantial reinvestment for the future. Its ability to generate high returns on capital and equity is a key strength. However, the company's operational efficiency shows notable weaknesses. It is slow to collect payments from customers and does not generate revenue from its assets as effectively as it could. This indicates that while the company is growing, its management of working capital is an area of concern. The future outlook appears positive, driven by strong growth and profitability, but its performance will depend on improving the efficiency of its expanding asset base.
Rossari Biotech Ltd. presents a strong financial profile, characterized by exceptional growth, outstanding profitability, and a very secure, low-debt structure. The company is expanding rapidly, with significant increases in revenue, profits, and assets, indicating high market demand and substantial reinvestment for the future. Its ability to generate high returns on capital and equity is a key strength. However, the company's operational efficiency shows notable weaknesses. It is slow to collect payments from customers and does not generate revenue from its assets as effectively as it could. This indicates that while the company is growing, its management of working capital is an area of concern. The future outlook appears positive, driven by strong growth and profitability, but its performance will depend on improving the efficiency of its expanding asset base.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
20.49
Industry Median
33.65
Small Cap Median
27.44
P/E RATIO
19.62
P/B RATIO
2.19
Industry Median
2.52
Small Cap Median
2.33
P/S RATIO
1.29
Industry Median
2.30
Small Cap Median
1.78
Others
PEG RATIO
0.00
EV/EBITDA RATIO
10.05
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹528.5 as on Jul 13, 2026.
The company is experiencing an exceptional period of expansion. It has demonstrated outstanding growth across all key metrics, including significant increases in sales, operating profits, and overall net income. This impressive performance is supported by a substantial increase in its asset base, indicating heavy investment in its future capabilities. This all-around high growth is a major strength, signaling strong market demand for its products and a successful business strategy that is driving the company forward.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 109.17 | 11.67 | 10.57 | 13.6 | 15.19 |
| Operating Profit Growth Rate | 48.39 | 21.2 | 12.11 | 6 | 7.92 |
| Earnings Per Share (EPS) Growth | 14.82 | 9.64 | 21.65 | 4.1 | 9.38 |
| Asset Growth Rate | 123.71 | 8.69 | 14.88 | 20.36 | 21.37 |
| Net Income Growth Rate | 22.5 | 9.18 | 22.43 | 3.82 | 9.56 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 27.03 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Platinum Industries Ltd | 8.59 | 24.43 | Neutral | 60.00 | 9.75 | 51.00 |
| 3 | Rossari Biotech Ltd | 8.46 | 19.62 | Neutral | 286.00 | 25.79 | 149.00 |
| 4 | Fineotex Chemical Ltd | 8.39 | 38.90 | Neutral | 135.00 | 0.79 | 125.00 |
| 5 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 30.36 | Neutral | 78.00 | 9.84 | 49.00 |
| 6 | Bhansali Engineering Polymers Ltd | 8.25 | 14.93 | Undervalued | 216.00 | 7.25 | 180.00 |
| 7 | Styrenix Performance Materials Ltd | 8.12 | 22.29 | Undervalued | 343.00 | 133.22 | 183.00 |
| 8 | Balaji Amines Ltd | 7.71 | 45.37 | Overvalued | 265.00 | 51.09 | 169.00 |
| 9 | Tatva Chintan Pharma Chem Ltd | 7.13 | 77.39 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 10 | Neogen Chemicals Ltd | 6.69 | 197.25 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 11 | Laxmi Organic Industries Ltd | 6.17 | 57.41 | Neutral | 171.00 | 2.86 | 79.00 |
| 12 | Yasho Industries Ltd | 6.09 | 141.89 | Neutral | 143.00 | 17.81 | 25.00 |
| 13 | Camlin Fine Sciences Ltd | 5.80 | 87.60 | Neutral | 107.00 | -1.72 | 24.00 |
| 14 | NOCIL Ltd | 5.27 | 51.48 | Neutral | 101.00 | 3.84 | 56.00 |
| 15 | Chemplast Sanmar Ltd | 4.81 | -11.26 | Neutral | 198.00 | -63.46 | -280.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT